Bristol-Myers Squibb

Renegade Researcher Says Alzheimer’s Drugs From Bristol-Myers, Pfizer May Be Unsafe Or Ineffective
Forbes
Mon, 08/23/10 - 10:06 am
Pfizer
Alzheimer's disease
Bristol-Myers Squibb
anti-amyloid
Eli Lilly
Eli Lilly Setback Could Pave Way For New Alzheimer’s Approach
Forbes
Fri, 08/20/10 - 12:45 pm
Eli Lilly
Alzheimer's disease
Pfizer
Elan
Bristol-Myers Squibb
Generic Risk For Gilead's Hepsera
Yahoo/Zacks.com
Fri, 08/20/10 - 10:56 am
Gilead Sciences
Hepsera
generics
Bristol-Myers Squibb
Merck
hepatitis B
Bristol-Myers cancer drug gets faster FDA review
Yahoo/AP
Wed, 08/18/10 - 04:53 pm
Bristol-Myers Squibb
FDA
melanoma
ipilimumab
Lilly's Alzheimer's disaster spells trouble for entire class
Fierce Biotech
Wed, 08/18/10 - 10:06 am
Eli Lilly
Alzheimer's disease
Elan
Bristol-Myers Squibb
JNJ
Pfizer
Double standard for big pharma bribes
CNN/Fortune
Tue, 08/17/10 - 11:58 am
bribery
FCPA
DOJ
GSK
Eli Lilly
Bristol-Myers Squibb
Merck
AstraZeneca
Big Pharma's Big Problem
Investopedia
Mon, 08/16/10 - 06:11 pm
Biogen Idec
Bristol-Myers Squibb
Genzyme
Pfizer
Sanofi
Affymetrix
US probes corruption in big pharma
FT.com
Fri, 08/13/10 - 07:27 am
DOJ
Merck
GSK
Pfizer
Bristol-Myers Squibb
Eli Lilly
SEC
Marginal Performance at Abbott Laboratories
Motley Fool
Wed, 08/11/10 - 09:12 am
Abbott Laboratories
Valeant Pharmaceuticals
Merck
Celgene
Bristol-Myers Squibb
Bristol-Myers’ Uniquely Awful Sexual Harassment Policy: Silence Is Consent
BNET Pharma
Tue, 08/10/10 - 09:12 am
Bristol-Myers Squibb
sexual harassment
CyDex Pharmaceuticals licenses compound that could expand market reach Read more: CyDex Pharmaceuticals licenses compound that could expand market reach - Kansas City Business Journal
bizjournals
Sat, 08/7/10 - 11:59 am
CyDex Pharmaceuticals
Captisol
Pfizer
Bristol-Myers Squibb
Prism Pharmaceuticals
Big Pharma Won't Wait in Rush for Biotech's Drugs
WSJ Online
Wed, 08/4/10 - 11:30 am
Bristol-Myers Squibb
ZymoGenetics
Amgen
Big Pharma
Abbott Laboratories
Array Biopharma
3 Development-Stage Drugmakers Worth Watching
Motley Fool
Sun, 08/1/10 - 02:29 pm
InterMune
Medivation
Exelixis
Bristol-Myers Squibb
GSK
Roche
Seattle Genetics
Regeneron
Drug Company as Masochist: Bristol-Myers Takes Needless Whipping for HIV Drug Prices
BNET Pharma
Wed, 07/28/10 - 12:45 am
HIV
drug pricing
Bristol-Myers Squibb
Jury Still Out on Exelixis's Long Term Potential
Seeking Alpha
Mon, 07/26/10 - 11:00 am
Sanofi
Novartis
GSK
Exelixis
cancer
Bristol-Myers Squibb
Arqule
Why I Bought Call Options on Mylan
Seeking Alpha
Fri, 07/23/10 - 06:34 am
Mylan
Eli Lilly
JNJ
Bristol-Myers Squibb
Teva Pharmaceuticals
generics
Bristol-Myers Profit Beats Estimates on Plavix, HIV Treatments
Bloomberg
Thu, 07/22/10 - 08:44 am
earnings
Bristol-Myers Squibb
15% Revenue Growth Is Good for Pfizer, but Not Gilead
Motley Fool
Thu, 07/22/10 - 08:43 am
Pfizer
Gilead Sciences
earnings
JNJ
Bristol-Myers Squibb
Merck
Drug Trials Test Bold Plan to Slow Alzheimer’s
New York Times
Sat, 07/17/10 - 11:14 am
Alzheimer's disease
Bristol-Myers Squibb
FDA takes a closer look at possible cancer risks of widely used blood pressure medicines
Star Ledger, NJ
Fri, 07/16/10 - 09:26 am
FDA
cancer
ARBs
Merck
Cozaar
Bristol-Myers Squibb
Avapro
Atacand
Benicar
Diovan
Micardis
Teveten

Pages